Tyche Wealth Partners LLC Invests $256,000 in MetLife, Inc. (NYSE:MET)

Tyche Wealth Partners LLC acquired a new position in shares of MetLife, Inc. (NYSE:MET) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 3,871 shares of the financial services provider’s stock, valued at approximately $256,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. IHT Wealth Management LLC grew its stake in shares of MetLife by 4.5% during the 4th quarter. IHT Wealth Management LLC now owns 3,466 shares of the financial services provider’s stock worth $251,000 after purchasing an additional 150 shares during the period. Carolinas Wealth Consulting LLC grew its stake in shares of MetLife by 26.4% during the 1st quarter. Carolinas Wealth Consulting LLC now owns 767 shares of the financial services provider’s stock worth $54,000 after purchasing an additional 160 shares during the period. Harbour Investments Inc. grew its stake in shares of MetLife by 3.2% during the 4th quarter. Harbour Investments Inc. now owns 5,269 shares of the financial services provider’s stock worth $381,000 after purchasing an additional 162 shares during the period. Eley Financial Management Inc grew its stake in shares of MetLife by 1.0% during the 3rd quarter. Eley Financial Management Inc now owns 16,348 shares of the financial services provider’s stock worth $1,028,000 after purchasing an additional 168 shares during the period. Finally, Austin Private Wealth LLC grew its stake in MetLife by 4.1% in the 4th quarter. Austin Private Wealth LLC now owns 4,367 shares of the financial services provider’s stock valued at $289,000 after acquiring an additional 170 shares during the period. Institutional investors and hedge funds own 89.81% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on MET shares. The Goldman Sachs Group raised shares of MetLife from a “neutral” rating to a “buy” rating and lifted their price target for the company from $70.00 to $80.00 in a research note on Monday, January 8th. Morgan Stanley lifted their price target on shares of MetLife from $80.00 to $82.00 and gave the company an “overweight” rating in a research note on Monday. UBS Group dropped their price target on shares of MetLife from $87.00 to $82.00 and set a “buy” rating on the stock in a research note on Monday, February 5th. Piper Sandler lifted their price target on shares of MetLife from $74.00 to $85.00 and gave the company an “overweight” rating in a research note on Friday, April 5th. Finally, Keefe, Bruyette & Woods lifted their price target on shares of MetLife from $82.00 to $87.00 and gave the company an “outperform” rating in a research note on Wednesday, April 10th. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $79.23.

Insider Transactions at MetLife

In other news, EVP Bill Pappas sold 27,000 shares of MetLife stock in a transaction on Monday, March 18th. The stock was sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the transaction, the executive vice president now owns 57,768 shares in the company, valued at approximately $4,174,893.36. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, insider Ramy Tadros sold 4,026 shares of the business’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total value of $289,469.40. Following the sale, the insider now directly owns 146,981 shares in the company, valued at approximately $10,567,933.90. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Bill Pappas sold 27,000 shares of the business’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the completion of the sale, the executive vice president now owns 57,768 shares in the company, valued at $4,174,893.36. The disclosure for this sale can be found here. Insiders own 0.32% of the company’s stock.

MetLife Trading Down 0.0 %

Shares of MET opened at $68.92 on Thursday. MetLife, Inc. has a 52-week low of $48.95 and a 52-week high of $74.68. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.53. The firm’s fifty day moving average is $70.98 and its two-hundred day moving average is $66.68. The stock has a market cap of $49.83 billion, a PE ratio of 37.66, a price-to-earnings-growth ratio of 0.52 and a beta of 1.04.

MetLife (NYSE:MET) last posted its quarterly earnings results on Wednesday, January 31st. The financial services provider reported $1.93 EPS for the quarter, missing the consensus estimate of $1.95 by ($0.02). MetLife had a return on equity of 19.48% and a net margin of 2.36%. The company had revenue of $18.72 billion for the quarter, compared to analysts’ expectations of $18.07 billion. Research analysts forecast that MetLife, Inc. will post 8.71 earnings per share for the current fiscal year.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.